amoxapine has been researched along with Liver Neoplasms in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, X | 1 |
| Zheng, Z | 1 |
| Song, G | 1 |
| Zhang, Z | 1 |
| Liu, H | 1 |
| Kang, J | 1 |
| Sun, G | 2 |
| Huang, T | 1 |
| Li, X | 1 |
| Rong, D | 1 |
| Wang, K | 1 |
| Tang, W | 1 |
| Xia, Y | 1 |
1 other study available for amoxapine and Liver Neoplasms
| Article | Year |
|---|---|
Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma.
Topics: Amoxapine; B7-H1 Antigen; Carcinoma, Hepatocellular; Glucuronidase; Humans; Liver Neoplasms; MicroRN | 2022 |